FCER2 and B-cell chronic lymphocytic leukemia: In 1994 Matutes et al developed a scoring system for the diagnosis of CLL which is based on the immunophenotyping analysis of five markers CD5, CD23, FMC7, CD79b/CD22, and surface membrane immunoglobulin (SmIg).